Botulinum toxin A alleviates orofacial nociception induced by orthodontic tooth movement through nociceptin/orphanin-FQ pathway in rats

Copyright © 2020 Elsevier Ltd. All rights reserved..

OBJECTIVES: To investigate the effect and mechanism of botulinum neurotoxin type A (BoNT/A) in the modulation of orofacial nociception induced by orthodontic tooth movement in rats.

METHODS: An orofacial nociception model was established in male Sprague-Dawley rats by ligating closed-coil springs between incisors and ipsilateral molars. There were two group sets of animals. For the first group set, 120 rats were randomly divided into four groups: no-force group (n = 30), force + saline group (n = 30), force + low dose BoNT/A group (1U/6 μL, n = 30), and force + high dose BoNT/A group (1U/6 μL, n = 30). BoNT/A and saline were injected into periodontal ligament to explore the nociceptive effect of BoNT/A. Ipsilateral trigeminal ganglia (TG) were harvested for detecting the expression levels of nociceptin/orphanin-FQ (N/OFQ). For the second group set, 36 rats were randomly divided into three force groups: BoNT/A + saline group (n = 12), BoNT/A + UFP-101 group (n = 12), and saline + UFP-101 group (n = 12). A potent N/OFQ receptor (NOP) antagonist (UFP-101) was used to examine the role of N/OFQ in BoNT/A-induced antinociception. Tooth-movement nociception level of all groups was evaluated by bite force and rat grimace scale (RGS) at baseline, day 1, day 3, day 5, day 7, day 14.

RESULTS: The behavioral assessments showed the orofacial nociception level in the force + low dose BoNT/A group and force + high dose BoNT/A group were lower than that in the force + saline group. No significant difference was observed in orofacial nociception among no-force group, force + low dose and force + high dose group. The expression levels of N/OFQ in TG were elevated from day 1 and maintained a high level, presenting in descending order among the force + high dose, force + low dose, force + saline and no-force group, respectively. The nociception level of the BoNT/A + UFP-101 group was higher than that of the BoNT/A + saline group. No significant difference was observed between the BoNT/A + UFP-101 group and the saline + UFP-101 group.

CONCLUSIONS: BoNT/A can exert an antinociceptive effect on orofacial nociception induced by tooth movement by stimulating the expression of N/OFQ in TG.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:117

Enthalten in:

Archives of oral biology - 117(2020) vom: 22. Sept., Seite 104817

Sprache:

Englisch

Beteiligte Personen:

Lyu, Jiahong [VerfasserIn]
Wen, Jing [VerfasserIn]
Guo, Rui [VerfasserIn]
Zhu, Yafen [VerfasserIn]
Liang, Hengyan [VerfasserIn]
Gao, Meiya [VerfasserIn]
Wang, Hang [VerfasserIn]
Lai, Wenli [VerfasserIn]
Long, Hu [VerfasserIn]

Links:

Volltext

Themen:

Antinociception
Botulinum Toxins, Type A
Botulinum toxin A
EC 3.4.24.69
Journal Article
Nociceptin/orphanin-FQ
Opioid Peptides
Orofacial nociception
Receptors, Opioid
Trigeminal ganglia

Anmerkungen:

Date Completed 24.11.2020

Date Revised 13.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.archoralbio.2020.104817

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM311818927